Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Utility of whole-body (head-to-toe) PET/CT in the evaluation of melanoma and sarcoma patients.

Webb HR, Latifi HR, Griffeth LK.

Nucl Med Commun. 2018 Jan;39(1):68-73. doi: 10.1097/MNM.0000000000000778.

PMID:
29189489
2.

Optimal interpretative strategy for preoperative parathyroid scintigraphy.

Bahador FM, Latifi HR, Grossman SJ, Oza UD, Xu H, Griffeth LK.

Clin Nucl Med. 2015 Feb;40(2):116-22. doi: 10.1097/RLU.0000000000000626.

PMID:
25525929
3.

Positron emission tomography for subsequent treatment strategy in oncology.

Griffeth LK, Hillner BE, Shields AF, Siegel BA.

J Clin Oncol. 2014 Sep 1;32(25):2811-2. doi: 10.1200/JCO.2013.54.8677. Epub 2014 Jul 14. No abstract available.

PMID:
25024080
4.

Facelift and patterns of lymphatic drainage.

Meade RA, Teotia SS, Griffeth LK, Barton FE.

Aesthet Surg J. 2012 Jan;32(1):39-45. doi: 10.1177/1090820X11430683. Erratum in: Aesthet Surg J. 2012 Mar 1;32(3):368.

PMID:
22231411
5.

Visualization of discrete sacral foramina as an ancillary sign of superscan.

Harshman LK, Latifi HR, Griffeth LK.

Clin Nucl Med. 2011 Jan;36(1):21-4. doi: 10.1097/RLU.0b013e3181feeb8c.

PMID:
21157202
6.

PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas.

Sattar T, Griffeth LK, Latifi HR, Glass J, Munker R, Lilien DL.

J La State Med Soc. 2006 Jul-Aug;158(4):193-201.

PMID:
17022364
7.

Oncologic positron emission tomography: a surgical perspective.

Moore TO, Griffeth LK.

Proc (Bayl Univ Med Cent). 2003 Jan;16(1):13-20. No abstract available.

8.

Use of PET/CT scanning in cancer patients: technical and practical considerations.

Griffeth LK.

Proc (Bayl Univ Med Cent). 2005 Oct;18(4):321-30.

9.

Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease.

Munker R, Glass J, Griffeth LK, Sattar T, Zamani R, Heldmann M, Shi R, Lilien DL.

Ann Oncol. 2004 Nov;15(11):1699-704.

PMID:
15520074
10.

Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.

Dehdashti F, Siegel BA, Griffeth LK, Fusselman MJ, Trask DD, McGuire AH, McGuire DJ.

Radiology. 1996 Jul;200(1):243-7.

PMID:
8657920
11.

FDG-PET evaluation of indeterminate pancreatic masses.

Ho CL, Dehdashti F, Griffeth LK, Buse PE, Balfe DM, Siegel BA.

J Comput Assist Tomogr. 1996 May-Jun;20(3):363-9.

PMID:
8626891
12.

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.

Dehdashti F, Mortimer JE, Siegel BA, Griffeth LK, Bonasera TJ, Fusselman MJ, Detert DD, Cutler PD, Katzenellenbogen JA, Welch MJ.

J Nucl Med. 1995 Oct;36(10):1766-74.

13.

Results of a clinical receiver operating characteristic study comparing filtered backprojection and maximum likelihood estimator images in FDG PET studies.

Llacer J, Veklerov E, Baxter LR, Grafton ST, Griffeth LK, Hawkins RA, Hoh CK, Mazziotta JC, Hoffman EJ, Metz CE.

J Nucl Med. 1993 Jul;34(7):1198-203.

14.

Brain metastases from non-central nervous system tumors: evaluation with PET.

Griffeth LK, Rich KM, Dehdashti F, Simpson JR, Fusselman MJ, McGuire AH, Siegel BA.

Radiology. 1993 Jan;186(1):37-44.

PMID:
8416584
15.

Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease.

Powers WJ, Perlmutter JS, Videen TO, Herscovitch P, Griffeth LK, Royal HD, Siegel BA, Morris JC, Berg L.

Neurology. 1992 Apr;42(4):765-70.

PMID:
1565229
16.

PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.

Griffeth LK, Dehdashti F, McGuire AH, McGuire DJ, Perry DJ, Moerlein SM, Siegel BA.

Radiology. 1992 Jan;182(1):185-94.

PMID:
1727280
17.

Positron emission tomography in the study of acute radiation effects on renal blood flow in dogs.

Kuten A, Roval HD, Griffeth LK, Mintum MA, Perez CA, Wasserman TH, Ter-Pogossian MM.

Int Urol Nephrol. 1992;24(5):527-9.

PMID:
1459830
18.

Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas.

Dehdashti F, McGuire AH, Van Brocklin HF, Siegel BA, Andriole DP, Griffeth LK, Pomper MG, Katzenellenbogen JA, Welch MJ.

J Nucl Med. 1991 Aug;32(8):1532-7.

19.

Cross-sectional imaging of the patellofemoral joint and surrounding structures.

Conway WF, Hayes CW, Loughran T, Totty WG, Griffeth LK, el-Khoury GY, Shellock FG.

Radiographics. 1991 Mar;11(2):195-217.

PMID:
2028059
20.

Sex-dependent differences in N-(3-[18F]fluoropropyl)-N-nordiprenorphine biodistribution and metabolism.

Chesis PL, Griffeth LK, Mathias CJ, Welch MJ.

J Nucl Med. 1990 Feb;31(2):192-201.

PMID:
2313358
21.

Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways.

Griffeth LK, Rosen GM, Rauchman EJ.

Drug Metab Dispos. 1987 Nov-Dec;15(6):749-59.

PMID:
2893698
22.

Intrathecal administration of nitroxides as potential contrast agents for MR imaging.

Rosen GM, Griffeth LK, Brown MA, Drayer BP.

Radiology. 1987 Apr;163(1):239-43.

PMID:
3823443
23.

Effects of model traumatic injury on hepatic drug metabolism in the rat. V. Sulfation and acetylation.

Griffeth LK, Rosen GM, Rauckman EJ.

Drug Metab Dispos. 1985 Jul-Aug;13(4):398-405.

PMID:
2863101
24.

Effects of model traumatic injury on hepatic drug metabolism in the rat. IV. Glucuronidation.

Griffeth LK, Rosen GM, Rauckman EJ.

Drug Metab Dispos. 1985 Jul-Aug;13(4):391-7.

PMID:
2863100
25.

Pharmacokinetics of nitroxide NMR contrast agents.

Griffeth LK, Rosen GM, Rauckman EJ, Drayer BP.

Invest Radiol. 1984 Nov-Dec;19(6):553-62.

PMID:
6511263
26.
27.
28.

Effect of acute cocaine administration on the metabolism of antipyrine in vivo.

Kloss MW, Griffeth LK, Rosen GM, Rauckman EJ.

Biochem Pharmacol. 1983 Dec 15;32(24):3871-3. No abstract available.

PMID:
6661261
29.

Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.

Griffeth LK, Rosen GM, Tschanz C, Rauckman EJ.

Drug Metab Dispos. 1983 Nov-Dec;11(6):517-25.

PMID:
6140133

Supplemental Content

Loading ...
Support Center